United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Orgenesis Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
| ROA | -104.97% | -6.26% | -6.36% | -6.6% | -6.59% | -6.59% |
|---|---|---|---|---|---|---|
| Gross Margin | 15% | 15% | 15% | 15% | 15% | -198.74% |
| Total Assets | $14,552.00K | $16,839.50K | $18,122.65K | $19,508.75K | $21,006.06K | $22,623.51K |
| Net Income | -$55,361.00K | -$2,446.06K | -$2,638.64K | -$2,971.68K | -$3,195.36K | -$5,488.13K |